Roth Mkm Forecasts Strong Price Appreciation for Monogram Orthopaedics (NASDAQ:MGRM) Stock

Monogram Orthopaedics (NASDAQ:MGRM) had its target price lifted by Roth Mkm from $4.00 to $5.40 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has a buy rating on the stock.

Separately, Roth Capital raised Monogram Orthopaedics to a “strong-buy” rating in a report on Monday, December 9th.

Monogram Orthopaedics Stock Down 7.1 %

Shares of NASDAQ MGRM opened at $3.12 on Tuesday. The business’s 50 day moving average price is $2.61 and its 200 day moving average price is $2.51. The firm has a market cap of $110.10 million, a P/E ratio of -6.64 and a beta of 1.66. Monogram Orthopaedics has a 52 week low of $1.70 and a 52 week high of $4.90.

Monogram Orthopaedics (NASDAQ:MGRM) last announced its quarterly earnings results on Wednesday, March 12th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.03. As a group, research analysts expect that Monogram Orthopaedics will post -0.49 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Barclays PLC acquired a new position in shares of Monogram Orthopaedics during the 3rd quarter worth approximately $29,000. State Street Corp acquired a new position in shares of Monogram Orthopaedics during the 3rd quarter worth approximately $62,000. Geode Capital Management LLC raised its stake in shares of Monogram Orthopaedics by 1,267.4% during the 3rd quarter. Geode Capital Management LLC now owns 210,144 shares of the company’s stock worth $557,000 after buying an additional 194,776 shares during the period. Jane Street Group LLC acquired a new position in shares of Monogram Orthopaedics during the 4th quarter worth approximately $25,000. Finally, Northern Trust Corp raised its stake in shares of Monogram Orthopaedics by 110.6% during the 4th quarter. Northern Trust Corp now owns 45,873 shares of the company’s stock worth $109,000 after buying an additional 24,088 shares during the period. 0.45% of the stock is owned by institutional investors and hedge funds.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.